Protagenic Therapeutics Inc (PTIX)

$0.54 -0.03 (-4.74%)
Market Cap 1.43M
Revenue (ttm) 0.00
Net Income (ttm) -5.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 68,903
Avg Vol 132,478
Day's Range N/A - N/A
Shares Out 1.94M
Stochastic %K 25%
Beta 0.51
Analysts Strong Buy
Price Target $4.00

Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Industry: Biotechnology
Sector: Healthcare
Phone: (805) 699-5596
Address:
701 Anacapa Street, Suite C, Santa Barbara, United States
sadie444
sadie444 Mar. 9 at 7:31 PM
$PTIX additionally they filed for the outstanding quarter where they completed the merger addressing that outstanding NASDAQ issue. That leaves us now with getting the evaluation of the company up to meet NASDAQ listing standards and obviously addressing the value per share. But they are addressing all of the outstanding issues to regain compliance with NASDAQ.
1 · Reply
sadie444
sadie444 Mar. 9 at 7:22 PM
$PTIX 10Q just filed with the SEC. Surprise to the upside with a net gain of $1.14 p/s for Q4!!!!
0 · Reply
sadie444
sadie444 Mar. 6 at 2:49 AM
$PTIX New SEC filing made 3/3 “On February 17, 2026, Protagenic Therapeutics, Inc. entered into a Settlement Agreement with Alterola Biotech Inc., EMC2 Capital LLC, and the former stockholders of Phytanix Bio (collectively, the "Former Phytanix Stockholders”), in connection with the litigation styled Protagenic Therapeutics, Inc. v. Alterola Biotech Inc., et al., Case No. 2025-1238-KMM, pending in the Court of Chancery of the State of Delaware. The Settlement Agreement provides for, among other things, the dismissal of the Litigation and the execution of an agreement to terminate, and unwind the transactions contemplated by, the Share Exchange Agreement dated May 15, 2025 (the "SEA”). Pursuant to the SEA, PTIX had previously acquired 100% of the outstanding capital stock of Phytanix Bio, which transaction was disclosed in PTIX’s Current Reports on Form 8-K filed with the Securities and Exchange Commission on May 19, 2025 and August 28, 2025.
0 · Reply
Biotechguy21
Biotechguy21 Feb. 25 at 4:51 PM
$AGEN the pos games are almost over from this ceo and his team. look at $INKT and $PTIX to see what he has been upto. All three are pos companies and are almost broke. 🤡🤡🤡🤡🤡
0 · Reply
Biotechguy21
Biotechguy21 Feb. 18 at 12:23 PM
$AGEN $INKT $PTIX what do you think when you see this pic? 😂😂😂😂
0 · Reply
Biotechguy21
Biotechguy21 Feb. 16 at 8:48 PM
$AGEN this pos loves to flush money down the drain 24/7. Study up on these other two pos companies $PTIX $INKT and tell me what you notice 👀🤡😂💩💰
0 · Reply
Pig2market
Pig2market Feb. 10 at 3:13 PM
$PTIX garbage stock all day everyday.
0 · Reply
2_logs_higher
2_logs_higher Feb. 5 at 4:24 PM
$AGEN & $INKT $PTIX Articles like this make one wonder how much G pissed off the FDA and how long they will hold a grudge. Maybe the FDA should just say, once G departs, we will approve. Nothing soon for PTIX as a result of this article. https://www.statnews.com/2026/02/04/psilocybin-depression-psychedelic-drug-fast-track-blocked/
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 5 at 2:01 PM
$PTIX RSI: 42.63, MACD: -0.1810 Vol: 0.06, MA20: 0.54, MA50: 1.14 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Jan. 29 at 4:39 PM
$PTIX Can't guard the henhouse? OFF my Watchlist!
0 · Reply
Latest News on PTIX
No data available.
sadie444
sadie444 Mar. 9 at 7:31 PM
$PTIX additionally they filed for the outstanding quarter where they completed the merger addressing that outstanding NASDAQ issue. That leaves us now with getting the evaluation of the company up to meet NASDAQ listing standards and obviously addressing the value per share. But they are addressing all of the outstanding issues to regain compliance with NASDAQ.
1 · Reply
sadie444
sadie444 Mar. 9 at 7:22 PM
$PTIX 10Q just filed with the SEC. Surprise to the upside with a net gain of $1.14 p/s for Q4!!!!
0 · Reply
sadie444
sadie444 Mar. 6 at 2:49 AM
$PTIX New SEC filing made 3/3 “On February 17, 2026, Protagenic Therapeutics, Inc. entered into a Settlement Agreement with Alterola Biotech Inc., EMC2 Capital LLC, and the former stockholders of Phytanix Bio (collectively, the "Former Phytanix Stockholders”), in connection with the litigation styled Protagenic Therapeutics, Inc. v. Alterola Biotech Inc., et al., Case No. 2025-1238-KMM, pending in the Court of Chancery of the State of Delaware. The Settlement Agreement provides for, among other things, the dismissal of the Litigation and the execution of an agreement to terminate, and unwind the transactions contemplated by, the Share Exchange Agreement dated May 15, 2025 (the "SEA”). Pursuant to the SEA, PTIX had previously acquired 100% of the outstanding capital stock of Phytanix Bio, which transaction was disclosed in PTIX’s Current Reports on Form 8-K filed with the Securities and Exchange Commission on May 19, 2025 and August 28, 2025.
0 · Reply
Biotechguy21
Biotechguy21 Feb. 25 at 4:51 PM
$AGEN the pos games are almost over from this ceo and his team. look at $INKT and $PTIX to see what he has been upto. All three are pos companies and are almost broke. 🤡🤡🤡🤡🤡
0 · Reply
Biotechguy21
Biotechguy21 Feb. 18 at 12:23 PM
$AGEN $INKT $PTIX what do you think when you see this pic? 😂😂😂😂
0 · Reply
Biotechguy21
Biotechguy21 Feb. 16 at 8:48 PM
$AGEN this pos loves to flush money down the drain 24/7. Study up on these other two pos companies $PTIX $INKT and tell me what you notice 👀🤡😂💩💰
0 · Reply
Pig2market
Pig2market Feb. 10 at 3:13 PM
$PTIX garbage stock all day everyday.
0 · Reply
2_logs_higher
2_logs_higher Feb. 5 at 4:24 PM
$AGEN & $INKT $PTIX Articles like this make one wonder how much G pissed off the FDA and how long they will hold a grudge. Maybe the FDA should just say, once G departs, we will approve. Nothing soon for PTIX as a result of this article. https://www.statnews.com/2026/02/04/psilocybin-depression-psychedelic-drug-fast-track-blocked/
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 5 at 2:01 PM
$PTIX RSI: 42.63, MACD: -0.1810 Vol: 0.06, MA20: 0.54, MA50: 1.14 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
GJ_Rockabilt
GJ_Rockabilt Jan. 29 at 4:39 PM
$PTIX Can't guard the henhouse? OFF my Watchlist!
0 · Reply
Biotechguy21
Biotechguy21 Jan. 28 at 7:23 PM
$PTIX $AGEN $INKT well what do we have here? another Garo influenced pos???? 🤡🤡🤡😂😂😂💩💩💩
0 · Reply
Pig2market
Pig2market Jan. 26 at 3:46 PM
$PTIX loser.
0 · Reply
Pig2market
Pig2market Jan. 26 at 3:46 PM
$PTIX scam.
0 · Reply
Pig2market
Pig2market Jan. 26 at 3:46 PM
$PTIX trash.
0 · Reply
Pig2market
Pig2market Jan. 26 at 3:46 PM
$PTIX garbage.
0 · Reply
Pig2market
Pig2market Jan. 22 at 4:58 PM
$PTIX cmon you piece of garbage.
0 · Reply
Biotechguy21
Biotechguy21 Jan. 13 at 6:05 PM
$INKT $AGEN $PTIX all three pos stocks and do you know why? 👀👀🤡🤡😂😂
0 · Reply
Biotechguy21
Biotechguy21 Jan. 9 at 12:47 PM
$AGEN $IMMX $INKT $SNSE two of these are huge pos stocks. And add $PTIX and you have a trifecta of 💩
0 · Reply
sadie444
sadie444 Jan. 7 at 4:54 PM
$PTIX According to the SEC filing dated January 5, it is clear that the company intends to continue operations and meet the requirements for relisting on NASDAQ. As I mentioned in my previous post, there are several steps the company needs to take. Clearly, the merger presented challenges that the company was not fully prepared for, particularly concerning the financial accounting requirements necessary for a successful merger. As often happens with smaller companies, it seems the organization lacked sufficient internal support to facilitate a smooth merger. Let’s hope that the time required to complete the internal accounting measures needed for filing quarterly reports is kept to a minimum. Once these measures are completed and filed with the SEC, we can expect the secondary NASDAQ issue to be resolved, demonstrating that the valuation of the combined company significantly exceeds the minimum requirement for NASDAQ listing.
1 · Reply
MS1974
MS1974 Jan. 7 at 3:42 PM
$PTIX Rocket on OTC
0 · Reply
Biotechguy21
Biotechguy21 Jan. 5 at 7:55 PM
$AGEN $INKT $PTIX been saying this for years. All three are pos companies and look who is involved. What does that tell you? 👀😂🤡💰
0 · Reply
neversurrender2024
neversurrender2024 Jan. 5 at 7:40 PM
$AGEN $PTIX $INKT ptix was hit with a non compliance letter from NASDAQ.....ptix inkt and garos coaf charity all share same adress....
1 · Reply